Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Respiratory Tract Infections » Bronchitis
Diseases [C] » Respiratory Tract Diseases [C08] » Bronchial Diseases » Bronchitis
Diseases [C] » Respiratory Tract Diseases [C08] » Lung Diseases » Lung Diseases, Obstructive » Bronchitis
Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Infections » Bronchitis
Description
Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. MeSH
Hierarchy View
Subtype Terms (2)
Bronchiolitis
43 drugs (32 approved, 11 experimental)
Bronchitis, Chronic
62 drugs (49 approved, 13 experimental)
Phase 4 Indicated Drugs (21)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (10)
Organization Involved with Phase 4 Indications (41)
Adams Respiratory Therapeutics
Ahn-Gook Pharmaceuticals Co.,Ltd
Dutch Health Care Insurance Board
Jiujiang First People's Hospital
Katholieke Universiteit Leuven
Organization Involved with Phase 3 Indications (34)
Organization Involved with Phase 2 Indications (19)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (15)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
